Clubs How It Works

Markets Markets News MakklerAI My Portfolio · Pro

Makkler vs. eToro Makkler vs. Skool Makkler vs. YouTube

MakklerPRO About Us

Log In Get Started Free

Overview Stocks Crypto Currencies Commodities ETFs Options My watchlist

Makkler App

Faster and clearer

4171 Stock Price and Chart - GeneReach Biotechnology Corp. | Makkler

Overview/Stocks/4171

GeneReach Biotechnology Corp. 4171

TPEX · Taiwan · Health Technology

TWD 16.35-0.10 (-0.61%)

Market open· Oct 1, 2026, 5:30 AM UTC· TWD · Data may be delayed

Overview Financials Analysis Earnings Dividends Technicals Historical data News

Prices may be delayed and are for informational purposes only - not investment advice.

My Portfolio · Pro

Makkler vs. eToro

Makkler vs. Skool

Makkler vs. YouTube

Get Started Free

The portfolio-sharing platform connecting finance content creators with an audience that wants to learn.

Theme

Platform

Clubs Markets Markets News MakklerPRO Makkler Token How It Works Become a Creator

Compare

Makkler vs. eToro Makkler vs. Skool Makkler vs. YouTube

Company

About Us Contact

Legal

Terms of Service Privacy Policy Data Protection Notice Risk Disclosure Payment Policy

© 2026 Makkler. All rights reserved. Content on this platform does not constitute investment advice.

-13.49% · 6MFull-screen chart

TWD 20.85TWD 16.15

Apr 2, 2026Oct 1, 2026

Open TWD 16.45High TWD 16.45Low TWD 16.35Close TWD 16.35Volume 27.38K

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: TWD 16.45
Day range: TWD 16.35 – TWD 16.45
52-week range: TWD 16.05 – TWD 26.90
Volume: 27.83K
Market cap: TWD 955.05M
Avg. volume (1Y): 202.02K

Performance

1 week

+0.62%

1 month

-3.82%

3 months

-5.22%

6 months

-11.38%

Year to date

-13.72%

1 year

-8.91%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Medical Specialties
Country: Taiwan
Exchange: TPEX
Shares outstanding: 56.26M
ISIN: TW0004171004
Beta: 0.42

Technical view

Below averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.